Company CHINA MED

Equities

CHME

US1694911074

Pharmaceuticals

Market Closed - OTC Markets 09:30:19 2024-02-15 am EST 5-day change 1st Jan Change
0.0001 USD -99.64% Intraday chart for CHINA MED -.--% -.--%

Business Summary

China Medicine Corporation is a pharmaceutical company. The Company is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The Company's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The Company also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.

Managers

Managers TitleAgeSince
Chief Executive Officer 62 06-02-07
Director of Finance/CFO - 10-11-15

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 62 06-02-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,837,970 27,837,970 ( 100.00 %) 0 100.00 %

Company contact information

China Medicine Corp.

2/F, Guangri Tower No. 9 Siyounan Road, 1st Street

510600, Guangzhou

+

http://www.cmc621.com
address CHINA MED(CHME)